 |
Director, Molecular Neurobiology Unit, Douglas Institute
judes_dot_poirier_At_mcgill_dot_ca |
2008
Aleong R., Blain J. F., Poirier J. (2008). Pro-inflammatory cytokines modulate glial apolipoprotein E secretion, Curr Alzheimer Res, 5(1), 33-7.
Fiocco A. J., Poirier J., Joober R., Nair N., Lupien S. J. (2008). Acute and long-term associations between ApoE genetic polymorphism, cortisol levels, and declarative memory performance in older adults, Psychoneuroendocrinology, 33(5), 625-33.
Gauthier S., Poirier J. (2008). Current and future management of Alzheimer's disease, Alzheimers Dement, 4(1 Suppl 1), S48-50.
Khachaturian Z. S., Petersen R. C., Gauthier S., Buckholtz N., Corey-Bloom J. P., Evans B., Fillit H., Foster N., Greenberg B., Grundman M., Sano M., Simpkins J., Schneider L. S., Weiner M. W., Galasko D., Hyman B., Kuller L., Schenk D., Snyder S., Thomas R. G., Tuszynski M. H., Vellas B., Wurtman R. J., Snyder P. J., Frank R. A., Albert M., Doody R., Ferris S., Kaye J., Koo E., Morrison-Bogorad M., Reisberg B., Salmon D. P., Gilman S., Mohs R., Aisen P. S., Breitner J. C., Cummings J. L., Kawas C., Phelps C., Poirier J., Sabbagh M., Touchon J., Khachaturian A. S., Bain L. J. (2008). A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium, Alzheimers Dement, 4(3), 156-63.
Leduc V., Poirier J. (2008). Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels, Neurodegener Dis, 5(3-4), 225-7.
Poirier J. (2008). Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease, Alzheimers Dement, 4(1 Suppl 1), S91-7.
